The utility of annual growth velocity standard deviation scores and measurements of biochemical parameters in long-term treatment monitoring of children with 21-hydroxylase deficiency.


Dilek S. O., TURAN İ., GÜRBÜZ F., Celiloglu C., YÜKSEL B.

Hormones (Athens, Greece), vol.21, no.3, pp.391-397, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 21 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.1007/s42000-022-00354-1
  • Journal Name: Hormones (Athens, Greece)
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.391-397
  • Keywords: 21-hydroxylase deficiency, 17-hydroxyprogesterone, Annual growth velocity, Final height, CONGENITAL ADRENAL-HYPERPLASIA, MASS-SPECTROMETRY, HEIGHT, PHARMACOKINETICS, HYDROCORTISONE, THERAPY, PUBERTY, PLASMA, INDEX, LIFE
  • Çukurova University Affiliated: Yes

Abstract

Purpose This study aimed to investigate the utility of annual growth velocity (GV) standard deviation scores (SDSs) and compatibility and effectiveness of biochemical parameters in long-term treatment monitoring and management of 21-hydroxylase deficiency (21-OHD) in children.